Literature DB >> 18317821

Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli.

C-I Kang1, J-H Song, W S Oh, K S Ko, D R Chung, K R Peck.   

Abstract

To identify specific risk factors and clinical outcomes of community-acquired pneumonia (CAP) caused by gram-negative bacilli (GNB), we compared the clinical features and outcomes of patients with CAP due to GNB with those of patients with non-GNB pneumonia. We performed a prospective observational study of 912 cases of adult CAP in Asian countries from January 2002 to December 2004. Systemic laboratory evaluation for determining the etiology and clinical evaluation were performed. Of 912 cases with CAP, 93 (10.1%) cases were caused by GNB: 59 with K. pneumoniae, 25 P. aeruginosa, 7 Enterobacter species, 1 Acinetobacter baumannii, and 1 Serratia marcescens. CAP caused by GNB was more frequently associated with septic shock, malignancy, cardiovascular diseases, smoking, hyponatremia, and dyspnea, according to multivariate analysis (P < 0.05). Overall 30-day mortality rate was 7.3% (65/885). Mortality was significantly higher in the GNB group than in the non-GNB group [18.3% (17/93) vs. 6.1% (48/792); P < 0.001]. GNB as a causative microorganism was found to be one of the independent risk factors for mortality (adjusted OR = 2.63, 95% CI 1.02-6.78, P = 0.046) with nursing home residence, mechanical ventilation, cardiovascular disease, respiratory rate > 30/min, and hyponatremia (all P < 0.05). GNB was not only a frequent etiology of severe CAP but also an independent risk factor for mortality. Data suggest that an initial empirical antimicrobial coverage of GNB including P. aeruginosa should be seriously considered in cases of severe pneumonia, especially in patients with underlying malignancy, underlying cardiovascular diseases, smoking, septic shock, and hyponatremia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18317821     DOI: 10.1007/s10096-008-0485-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

1.  Epidemiology of community-acquired pneumonia in adults: a population-based study.

Authors:  J Almirall; I Bolíbar; J Vidal; G Sauca; P Coll; B Niklasson; M Bartolomé; X Balanzó
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

Review 2.  Prescribing guidelines for severe Pseudomonas infections.

Authors:  Helen Giamarellou
Journal:  J Antimicrob Chemother       Date:  2002-02       Impact factor: 5.790

3.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

4.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

Authors:  M Ruiz; S Ewig; M A Marcos; J A Martinez; F Arancibia; J Mensa; A Torres
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 5.  Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.

Authors:  M H Kollef
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

6.  Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit.

Authors:  P Moine; J B Vercken; S Chevret; C Chastang; P Gajdos
Journal:  Chest       Date:  1994-05       Impact factor: 9.410

Review 7.  Optimizing treatment outcomes in severe community-acquired pneumonia.

Authors:  Felipe Rodríguez de Castro; Antoni Torres
Journal:  Am J Respir Med       Date:  2003

8.  Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.

Authors:  Jordi Vallés; Jordi Rello; Ana Ochagavía; José Garnacho; Miguel Angel Alcalá
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

9.  Severe community-acquired pneumonia. Epidemiology and prognostic factors.

Authors:  A Torres; J Serra-Batlles; A Ferrer; P Jiménez; R Celis; E Cobo; R Rodriguez-Roisin
Journal:  Am Rev Respir Dis       Date:  1991-08

10.  Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis.

Authors:  Francisco Arancibia; Torsten T Bauer; Santiago Ewig; Josep Mensa; Julia Gonzalez; Michael S Niederman; Antoni Torres
Journal:  Arch Intern Med       Date:  2002-09-09
View more
  10 in total

1.  Poor clinical outcomes among pneumonia patients with schizophrenia.

Authors:  Yi-Hua Chen; Hsiu-Chen Lin; Herng-Ching Lin
Journal:  Schizophr Bull       Date:  2010-03-25       Impact factor: 9.306

2.  Bacteraemic community-acquired pneumonia due to Gram-negative bacteria: incidence, clinical presentation and factors associated with severity during hospital stay.

Authors:  L A Ruiz; A Gómez; C Jaca; L Martínez; B Gómez; R Zalacain
Journal:  Infection       Date:  2010-09-29       Impact factor: 3.553

3.  Impact of macrolide therapy in patients hospitalized with Pseudomonas aeruginosa community-acquired pneumonia.

Authors:  Elena Laserna; Oriol Sibila; Juan Felipe Fernandez; Diego Jose Maselli; Eric M Mortensen; Antonio Anzueto; Grant Waterer; Marcos I Restrepo
Journal:  Chest       Date:  2014-05       Impact factor: 9.410

Review 4.  South African guideline for the management of community-acquired pneumonia in adults.

Authors:  Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 5.  Risk Factors for Drug-Resistant Cap in Immunocompetent Patients.

Authors:  Francisco Arancibia; Mauricio Ruiz
Journal:  Curr Infect Dis Rep       Date:  2017-03       Impact factor: 3.725

6.  A Case of Community-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii in Korea.

Authors:  Young Woong Son; In Young Jung; Mi Young Ahn; Yong Duk Jeon; Hea Won Ann; Jin Young Ahn; Nam Su Ku; Sang Hoon Han; Jun Young Choi; Young Goo Song; June Myung Kim
Journal:  Infect Chemother       Date:  2017-12

7.  Community-acquired pneumonia and Gram-negative bacilli in Cambodia-incidence, risk factors and clinical characteristics.

Authors:  Malin Inghammar; Laurence Borand; Sophie Goyet; Blandine Rammaert; Vantha Te; Patrich Lorn Try; Bertrand Guillard; Philippe Buchy; Sirenda Vong; Eap Tek Chheng; Philippe Cavailler; Charles Mayaud; Arnaud Tarantola
Journal:  Trans R Soc Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.184

Review 8.  Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia.

Authors:  Mi Suk Lee; Jee Youn Oh; Cheol In Kang; Eu Suk Kim; Sunghoon Park; Chin Kook Rhee; Ji Ye Jung; Kyung Wook Jo; Eun Young Heo; Dong Ah Park; Gee Young Suh; Sungmin Kiem
Journal:  Infect Chemother       Date:  2018-06

Review 9.  Community-acquired pneumonia: an unfinished battle.

Authors:  Girish B Nair; Michael S Niederman
Journal:  Med Clin North Am       Date:  2011-10-05       Impact factor: 5.456

10.  Determinants of empirical antipseudomonal antibiotic prescription for adults with pneumonia in the emergency department.

Authors:  Nuria Angrill; Miguel Gallego; Juli Font; Jordi Vallés; Anisi Morón; Eduard Monsó; Jordi Rello
Journal:  BMC Pulm Med       Date:  2020-04-03       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.